Belizatinib/ceritinib/crizotinibDevelopement of multi-drug resistance in non small cell lung cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1658卷 / 1期

关键词：

D O I：

10.1007/s40278-017-32278-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：81 / 81

相关论文

共 50 条

[1] CrizotinibDevelopment of drug resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1733 (1) : 121 - 121
[2] OsimertinibAcquired drug resistance in non-small cell lung cancer: case report
Reactions Weekly, 2018, 1721 (1) : 226 - 226
[3] GefitinibDevelopment of drug resistance in non-small-cell lung cancer: case report
Reactions Weekly, 2019, 1763 (1) : 169 - 169
[4] Carboplatin/paclitaxelAcquired drug resistance and transformation of non-small cell lung cancer to small cell lung cancer: case report
Reactions Weekly, 2020, 1804 (1) : 88 - 88
[5] Ceritinib/crizotinibDevelopment of resistance in EML4-ALK-positive non-small cell lung cancer: case report
Reactions Weekly, 2017, 1635 (1) : 75 - 75
[6] GefitinibDevelopment of drug resistance in non-small cell lung cancer adenocarcinoma: case report
Reactions Weekly, 2017, 1668 (1) : 192 - 192
[7] Relationship between methylation status of multi-drug resistance protein(MRP) and multi-drug resistance in lung cancer cell lines
Liu Rui-jun
Zhong Hong
CHINESE JOURNAL OF CANCER RESEARCH, 2007, 19 (04) : 277 - 282
[8] Relationship between Methylation Status of Multi-drug Resistance Protein(MRP) and Multi-drug Resistance in Lung Cancer Cell Lines
柳瑞军
钟竑
Chinese Journal of Cancer Research, 2007, (04) : 277 - 282
[9] Relationship between Methylation Status of Multi-drug Resistance Protein (MRP) and Multi-drug Resistance in Lung Cancer Cell Lines
Li, Hong
Zhu, Yi-Fei
Zheng, Shi-Ying
Jiang, Dong
2009 INTERNATIONAL CONFERENCE ON FUTURE BIOMEDICAL INFORMATION ENGINEERING (FBIE 2009), 2009, : 548 - +
[10] ErlotinibDevelopment of drug resistance in EGFR mutationpositive Non-small cell lung cancer: case report
Reactions Weekly, 2016, 1598 (1) : 94 - 94

← 1 2 3 4 5 →